Novo Nordisk and The Creative Coalition Produce a Powerful COVID-19 and Obesity PSA Featuring OAC as Top Patient Resource
in 2020 News Releases, News Releases, OAC Newsroom on September 29, 2020

The Creative Coalition (a group of actors, writers, directs and designers) and Novo Nordisk are encouraging people to get to know the facts about COVID-19 and its impact on people living with obesity. The Creative Coalition and Novo Nordisk are featuring the OAC as the top patient resource and encouraging everyone to use OAC resources
Read Article

OAC’s Vice-Chair, Patty Neece, Comments on how COVID-19 affects People with Obesity
in 2020 News Releases, News Releases, OAC Newsroom on September 23, 2020

When the COVID-19 pandemic first began, it was unknown that obesity would be a major risk factor for the illness. It wasn’t until recently that dozens of studies began reporting that many of the sickest COVID-19 patients have been people with obesity. For people with obesity, the extra risk adds a psychological burden, says Patty
Read Article

The OAC Encourages Taking Action and Showing Support for the Treat and Reduce Obesity Act (TROA)
in 2020 News Releases, News Releases, OAC Newsroom on September 9, 2020

The Treat and Reduce Obesity Act (TROA) is a bipartisan bill that will give Medicare-eligible Americans greater access to obesity healthcare services, treatments and providers. Currently, this bill has Congressional support from 185 co-sponsors in the U.S. House of Representatives and Senate and has yet to come up for a committee or floor vote since
Read Article

X